HEALTHABC NEWS
Doctor explains study showing GLP-1s may lower breast cancer risk
A study of over 111,000 women aged 45 to 80 found that those using GLP-1 medications had a 30% reduced risk of developing breast cancer.
Related Signal
Adjacent reporting
- GLP-1 use could help lower risk of developing breast cancer — and more
- Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
- Breaking down findings of new study on weight loss drugs and breast cancer
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests
- Weight-loss jabs could cut breast cancer risk by nearly a third, major study suggests
- GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study